LBRX Stock Analysis: Buy, Sell, or Hold?
LBRX - LB Pharmaceuticals Inc Common Stock
$42.92
2.84 (7.09%)
▲
5d:
+23.4%
30d:
+28.39%
90d:
+36.56%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 11, 2026
7d
Get Alerted When LBRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: LBRX is 15.3% above its trading range ($37.24). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: LBRX is 15.3% above its trading range ($37.24). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: LBRX is currently trading at $42.92, which is considered extended relative to its 30-day fair value range of $31.03 to $37.24.
Technical Outlook: Technically, LBRX is in a uptrend. The price is approaching resistance at $43.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.1% recently.
Market Sentiment: LBRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $45.88 (+12.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LBRX is in a uptrend. The price is approaching resistance at $43.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.1% recently.
Market Sentiment: LBRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $45.88 (+12.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$31.03 -
$37.24
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
All Signals
- BEARISH: Price significantly overextended (+15.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.1%)
- BULLISH: Trading below Wall St target ($45.88)
- WARNING: Recommendation downgraded due to 15.3% overvaluation
Trading Range Analysis
30-Day Trading Range
$31.03 -
$37.24
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$31.04
Resistance Level
$43.46
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.63
Wall Street Target
$45.88
(+12.2%)
Share & Embed Analysis
Last updated: August 03, 2026 2:22 PM ET
Data refreshes hourly during market hours. Next update: 3:22 PM
Data refreshes hourly during market hours. Next update: 3:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LBRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |